Disruption of mitochondrial complex I induces progressive parkinsonism.

dc.contributor.authorGonzalez-Rodriguez, Patricia
dc.contributor.authorZampese, Enrico
dc.contributor.authorStout, Kristen A
dc.contributor.authorGuzman, Jaime N
dc.contributor.authorIlijic, Ema
dc.contributor.authorYang, Ben
dc.contributor.authorTkatch, Tatiana
dc.contributor.authorStavarache, Mihaela A
dc.contributor.authorWokosin, David L
dc.contributor.authorGao, Lin
dc.contributor.authorKaplitt, Michael G
dc.contributor.authorLopez-Barneo, Jose
dc.contributor.authorSchumacker, Paul T
dc.contributor.authorSurmeier, D James
dc.date.accessioned2025-01-07T16:02:15Z
dc.date.available2025-01-07T16:02:15Z
dc.date.issued2021-11-03
dc.description.abstractLoss of functional mitochondrial complex I (MCI) in the dopaminergic neurons of the substantia nigra is a hallmark of Parkinson's disease1. Yet, whether this change contributes to Parkinson's disease pathogenesis is unclear2. Here we used intersectional genetics to disrupt the function of MCI in mouse dopaminergic neurons. Disruption of MCI induced a Warburg-like shift in metabolism that enabled neuronal survival, but triggered a progressive loss of the dopaminergic phenotype that was first evident in nigrostriatal axons. This axonal deficit was accompanied by motor learning and fine motor deficits, but not by clear levodopa-responsive parkinsonism-which emerged only after the later loss of dopamine release in the substantia nigra. Thus, MCI dysfunction alone is sufficient to cause progressive, human-like parkinsonism in which the loss of nigral dopamine release makes a critical contribution to motor dysfunction, contrary to the current Parkinson's disease paradigm3,4.
dc.description.versionSi
dc.identifier.citationGonzález-Rodríguez P, Zampese E, Stout KA, Guzman JN, Ilijic E, Yang B, et al. Disruption of mitochondrial complex I induces progressive parkinsonism. Nature. 2021 Nov;599(7886):650-656.
dc.identifier.doi10.1038/s41586-021-04059-0
dc.identifier.essn1476-4687
dc.identifier.pmcPMC9189968
dc.identifier.pmid34732887
dc.identifier.pubmedURLhttps://pmc.ncbi.nlm.nih.gov/articles/PMC9189968/pdf
dc.identifier.unpaywallURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189968
dc.identifier.urihttps://hdl.handle.net/10668/27577
dc.issue.number7886
dc.journal.titleNature
dc.journal.titleabbreviationNature
dc.language.isoen
dc.organizationInstituto de Investigación Biomédica de Sevilla (IBIS)
dc.organizationSAS - Hospital Universitario Virgen del Rocío
dc.page.number650-656
dc.provenanceRealizada la curación de contenido 07/04/2025
dc.publisherNature Publishing Group
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, N.I.H., Extramural
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.relation.publisherversionhttps://doi.org/10.1038/s41586-021-04059-0
dc.rights.accessRightsRestricted Access
dc.subjectAnimals
dc.subjectDendrites
dc.subjectDopamine
dc.subjectFemale
dc.subjectMice
dc.subjectParkinsonian Disorders
dc.subjectSubstantia Nigra
dc.subject.decsDopamina
dc.subject.decsTrastornos Parkinsonianos
dc.subject.decsEnfermedad de Parkinson
dc.subject.decsNeuronas Dopaminérgicas
dc.subject.decsRatones
dc.subject.decsHumanos
dc.subject.decsMetabolismo
dc.subject.decsGenética
dc.subject.decsAxones
dc.subject.decsFenotipo
dc.subject.decsSobrevida
dc.subject.decsAprendizaje
dc.subject.decsLevodopa
dc.subject.meshAxons
dc.subject.meshCell Death
dc.subject.meshDisease Models, Animal
dc.subject.meshDisease Progression
dc.subject.meshDopaminergic Neurons
dc.subject.meshElectron Transport Complex I
dc.subject.meshLevodopa
dc.subject.meshMale
dc.subject.meshMotor Skills
dc.subject.meshNADH Dehydrogenase
dc.subject.meshPhenotype
dc.titleDisruption of mitochondrial complex I induces progressive parkinsonism.
dc.typeresearch article
dc.type.hasVersionAM
dc.volume.number599

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
RISalud_Accesorestringido.pdf
Size:
93.39 KB
Format:
Adobe Portable Document Format